  Neutropenic<disease> sepsis<disease> in haemato-/ oncological patients is a medical emergency , as infections may show a fulminant clinical course. Early differentiation between sepsis<disease> and febrile neutropenic response often proves to be challenging. To assess the severity of the illness , different tools , which are discussed in this article , are available. Once the diagnosis has been established , the correct use of early empirical antibiotic and antifungal treatment is key in improving patient survival. Therefore , profound knowledge of local resistance patterns is mandatory and carefully designed antibiotic regimens have to be established in cooperation with local microbiologists or infectious<disease> diseases<disease> specialists. In the following , identification , therapy and management of high-risk , neutropenic patients will be reviewed based on experimental and clinical studies , guidelines and reviews.